(Q34526387)

2 August 2017

1 reference

title

Rituximab: enhancing stem cell transplantation in mantle cell lymphoma (English)

1 reference

stem cell transplantation

2 August 2017

main subject

1 reference

1 reference

A M Gianni

1

1 reference

2 August 2017

S Cortelazzo

2

1 reference

2 August 2017

M Magni

3

1 reference

2 August 2017

M Martelli

4

1 reference

2 August 2017

Michelangelo Cooperative

5

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

Bone Marrow Transplantation

2 August 2017

published in

1 reference

2 August 2017

volume

29 Suppl 1

1 reference

2 August 2017

page(s)

S10-3

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703296

2 August 2017

exact match

0 references

cites work

The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703296

Hyper-CVAD and high-dose methotrexate/cytarabine followed by stem-cell transplantation: an active regimen for aggressive mantle-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703296

High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703296

High-dose chemotherapy with hematopoietic stem cell transplantation in patients with mantle cell or diffuse centrocytic non-Hodgkin’s lymphomas: a single center experience on 18 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703296

Negative immunomagnetic ex vivo purging combined with high-dose chemotherapy with peripheral blood progenitor cell autograft in follicular lymphoma patients: evidence for long-term clinical and molecular remissions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703296

inferred from DOI database lookup

7 January 2021

based on heuristic

In vivo depletion of B cells using a combination of high-dose cytosine arabinoside/mitoxantrone and rituximab for autografting in patients with non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703296

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.BMT.1703296

1 reference

Dimensions Publication ID

2 August 2017

1018556722

0 references

1 reference